Regulation of Fli1 gene expression and lupus

被引:13
|
作者
Nowling, Tamara K.
Gilkeson, Gary S.
机构
[1] Med Univ S Carolina, Dept Med, Div Rheumatol, Charleston, SC 29425 USA
[2] Ralph H Johnson VAMC, Med Res Serv, Charleston, SC 29425 USA
关键词
Ets; Fli1 gene expression; transcription; lupus; lymphocytes;
D O I
10.1016/j.autrev.2005.10.005
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Ets transcription factors function throughout development in such varied processes as cellular proliferation, apoptosis, differentiation and migration. Many have been implicated to play important roles in hematopoiesis, vasculogenesis/angiogenesis and myogenesis. Fli1 is an Ets family member that is essential for development and increasing evidence suggests modulating Fli1 gene expression impacts lymphocyte function and is important in the autoimmune disease lupus. Presently, it is unknown how Fli1 gene expression is controlled in lymphocytes. Identifying upstream regulators of Fli1 in lymphocytes will be critical for understanding lymphocyte development and the consequences of dysregulation and may be of value in developing future treatments for Jupus. Published by Elsevier B.V.
引用
收藏
页码:377 / 382
页数:6
相关论文
共 50 条
  • [31] Ectopic Expression of ERG and FLI1 Enforce a Megakaryocyte Phenotype Independent of GATA-1.
    Stankiewicz, Monika J.
    Crispino, John
    BLOOD, 2008, 112 (11) : 981 - 981
  • [32] Oncogenic Fusion Protein EWS/FLI1 Down-regulates Gene Expression by Both Transcriptional and Posttranscriptional Mechanisms
    France, Kelly A.
    Anderson, Jennifer L.
    Park, Ann
    Denny, Christopher T.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (26) : 22750 - 22757
  • [33] The orchestration of scleroderma-specific gene program in the skin by transcription factor Fli1
    Asano, Y.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2016, 57 : 8 - 8
  • [34] TARGETING EWS-FLI1 DRIVING GENE: PRELIMINARY DATA OF PHASE 1 PBI-ShRNA EWS/FLI1 LIPOPLEX
    Ghisoli, Maurizio
    Maning, Luisa
    Nemunaitis, John
    Rao, Donald
    Wallraven, Gladice
    Jay, Chris
    PEDIATRIC BLOOD & CANCER, 2018, 65
  • [35] Abnormal expression of FLI1 protein is an adverse prognostic factor in acute myeloid leukemia
    Kornblau, Steven M.
    Qiu, Yi Hua
    Zhang, Nianxiang
    Singh, Neera
    Faderl, Stefan
    Ferrajoli, Alessandra
    York, Heather
    Qutub, Amina A.
    Coombes, Kevin R.
    Watson, Dennis K.
    BLOOD, 2011, 118 (20) : 5604 - 5612
  • [36] FLI1 Regulates Histamine Decarboxylase Expression to Control Inflammation Signaling and Leukemia Progression
    Hu, Jifen
    Gao, Jian
    Wang, Chunlin
    Liu, Wuling
    Hu, Anling
    Xiao, Xiao
    Kuang, Yi
    Yu, Kunlin
    Gajendran, Babu
    Zacksenhaus, Eldad
    Pan, Weidong
    Ben-David, Yaacov
    JOURNAL OF INFLAMMATION RESEARCH, 2023, 16 : 2007 - 2020
  • [37] The role of FLI1 in breast cancer development and progression
    Scheiber, Melissa Nicole
    Watson, Patricia M.
    Findlay, Victoria J.
    Rumboldt, Tihana
    Watson, Dennis K.
    CANCER RESEARCH, 2011, 71
  • [38] FLI1 is a novel ETS transcription factor involved in gene fusions in prostate cancer
    Paulo, Paula
    Barros-Silva, Joao D.
    Ribeiro, Franclim R.
    Ramalho-Carvalho, Joao
    Jeronimo, Carmen
    Henrique, Rui
    Lind, Guro E.
    Skotheim, Rolf I.
    Lothe, Ragnhild A.
    Teixeira, Manuel R.
    GENES CHROMOSOMES & CANCER, 2012, 51 (03): : 240 - 249
  • [39] Discovery of microvascular miRNAs using public gene expression data: miR-145 is expressed in pericytes and is a regulator of Fli1
    Larsson, Erik
    Fuchs, Peder Fredlund
    Heldin, Johan
    Barkefors, Irmeli
    Bondjers, Cecilia
    Genove, Guillem
    Arrondel, Christelle
    Gerwins, Par
    Kurschat, Christine
    Schermer, Bernhard
    Benzing, Thomas
    Harvey, Scott J.
    Kreuger, Johan
    Lindahl, Per
    GENOME MEDICINE, 2009, 1
  • [40] Persistent down-regulation of Fli1, a suppressor of collagen transcription, in fibrotic scleroderma skin
    Kubo, M
    Czuwara-Ladykowska, J
    Moussa, O
    Markiewicz, M
    Smith, E
    Silver, RM
    Jablonska, S
    Blaszczyk, M
    Watson, DK
    Trojanowska, M
    AMERICAN JOURNAL OF PATHOLOGY, 2003, 163 (02): : 571 - 581